Management of Metastatic Colorectal Cancer (mCRC): Real-World Recommendations

Area of Science:

• Oncology
• Gastroenterology
• Medical Practice

Background:

• Metastatic colorectal cancer (mCRC) is a complex, heterogeneous disease.
• Effective management requires dynamic, individualized strategies.
• Community oncologists need accessible, real-world guidance.

Purpose of the Study:

• To develop practical, real-world recommendations for mCRC management.
• To provide a ready reference for community oncologists.
• To synthesize current literature and expert experience.

Main Methods:

• Expert panel convened with academic and real-world mCRC experience.
• Comprehensive review of current literature.
• Integration of insights from clinical practice.

Main Results:

• Recommendations cover molecular testing, palliative approaches, doublet/triplet chemotherapy, and targeted therapies (anti-VEGF, anti-EGFR).
• Pembrolizumab use for specific tumor subtypes (MSI-high/dMMR) in first-line.
• Management of distinct left/right-sided tumors and oligometastatic disease (curative intent options).
• Advanced strategies include induction-maintenance and perioperative chemotherapy.
• Subsequent line treatments can utilize first-line standards; specific driver mutations guide targeted biological therapy.

Conclusions:

• Multidisciplinary team management is crucial.
• Shared decision-making empowers patients and caregivers.
• Personalized treatment based on tumor characteristics and patient factors is key.